Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Castration-resistant Prostate Cancer × cabozantinib × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 27 Osteosarcoma 5 Neuroendocrine Tumors 4 Colorectal Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Sarcoma, Ewing 3 Neoplasms 3 Melanoma 3 Kidney Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Medullary 3 Adrenocortical Carcinoma 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Brain Neoplasms 2 von Hippel-Lindau Disease 1 Wilms Tumor 1 Urachal adenocarcinoma 1

Interventions

olaparib 3 darolutamide 2 Docetaxel 2 Abiraterone Acetate 2 testosterone 17 beta-cypionate 1 sarilumab 1 radium Ra 223 dichloride 1 fludarabine phosphate 1 fludarabine 1 enfortumab vedotin 1 cemiplimab 1 cabazitaxel 1 Standard of Care 1 Radium-223 1 Prednisone 1 Prednisolone 1 PSMA-617 1 Nivolumab 1 Gonadotropin-Releasing Hormone 1 Cyclophosphamide 1 Blood Specimen Collection 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡